C1q Measurement Protocol by ELISA
GUIDELINE
This experiment describes the procedure for the enzyme-linked immunosorbent assay C1q assay. The binding of solid-phase condensed IgG encapsulated on a plastic plate to enzyme-linked C1q is inhibited by immune complexes in the specimen, making it a competitive inhibition test. To avoid interference from endogenous C1q in the specimen, it should be removed beforehand with IgG immunosorbent.
METHODS
- Encapsulated cohesive IgG is taken from cohesive IgG (100 μg/ml) dialyzed overnight by 0.02 mol/L Tris-HCl buffer (pH 9.0) and added into the wells of polystyrene plates. 100 μl per well, after being encapsulated for 30 min at 37°C. The wells are washed three times with buffer, the 1st and 3rd times with 0.2 mol/L Tris-HCl buffer (pH 7.4), and the 2nd time with the same buffer containing 0.05% Tween20). Vacuum dry and store at 4°C.
- Take 50 μl of serum specimen, add 50 μl of 0.2 mol/L EDTA (pH 7.6), and act for 10 min at room temperature to free endogenous C1q. Then add 500 μl of IgG immunosorbent, oscillate at room temperature for 20 min, and then centrifuge at 500 r/min for 5 min to obtain 1:10 diluted supernatant.
- Take the plastic reaction plate that has been coated with coagulated IgG, add 90 μl of the above supernatant and 10 μl of enzyme-linked C1q (1:100, 200 dilution) to each well, and react at room temperature for 20 min. Then, wash 3 times with 0.2 mol/L Tris-HCl buffer (pH 7.4) containing 0.2 mol/L NaCl, 0.05% Tween20, and then add 100 μl of substrate solution (pH 6.0, 0.1 mol/L phosphate citrate buffer in 50 ml, add o-phenylenediamine 20 mg, 30% (W/V) hydrogen peroxide 10 μl), let it rest for 30 min at room temperature, add 2 mol/L sulfuric acid 50 μl to abort the reaction, and read the absorbance value at 492 nm. For quantification, a standard curve can be made with coagulated IgG to measure the relative content of immune complexes.
NOTES
- Ensure proper coating of the ELISA plate with the capture antibody specific for C1q. The coating buffer, incubation time, and temperature should be carefully followed as per the protocol to achieve optimal capture of the C1q protein.
- Thoroughly block the coated wells to prevent nonspecific binding of other proteins to the plate. Common blocking agents include BSA (bovine serum albumin) or non-fat dry milk. Follow the recommended blocking buffer, incubation time, and temperature stated in the protocol.
- Prepare a precise standard curve using known concentrations of the C1q standard. This is essential for accurate quantification of C1q levels in the samples. Handle the standard curve samples carefully to avoid introducing variability.
- Thorough and consistent washing of the plate between steps is essential to remove unbound substances and reduce background noise. Follow the recommended wash buffer, wash times, and agitation methods to minimize variability.
RELATED PRODUCTS & SERVICES
For research use only. Not for any other purpose.
Resources
- FAQ
- Protocol
- Cell Culture Guide
- Technical Bulletins
-
Explore & Learn
-
Cell Biology
- Monocytes vs. Macrophages
- How to Detect and Remove Endotoxins in Biologics?
- Comparison of Different Methods to Measure Cell Viability
- What Are Myeloid Cell Markers?
- How to Start Your Culture: Thawing Frozen Cells
- Biomarkers and Signaling Pathways in Tumor Stem Cells
- Techniques for Cell Separation
- Comparison of the MSCs from Different Sources
- T Cell Activation and Expansion
- How to Isolate and Analyze Tumor-Infiltrating Leukocytes?
- Contamination of Cell Cultures & Treatment
- Generation and Applications of Neural Stem Cells
- Stem Cell Markers
- CFU Assay for Hematopoietic Cell
- Circulating Tumor Cells as Cancer Biomarkers in the Clinic
- Cell Cryopreservation Techniques and Practices
- Guidelines for Cell Banking to Ensure the Safety of Biologics
- How to Assess the Migratory and Invasive Capacity of Cells?
- What are the Differences Between M1 and M2 Macrophages?
- Mesenchymal Stem Cells: A Comprehensive Exploration
- What Cell Lines Are Commonly Used in Biopharmaceutical Production?
- Organoid Differentiation from Induced Pluripotent Stem Cells
- Quantification of Cytokines
- Tips For Cell Cryopreservation
- STR Profiling—The ID Card of Cell Line
- Comparison of Several Techniques for the Detection of Apoptotic Cells
- Cryopreservation of Cells Step by Step
- What are PBMCs?
- Enrichment, Isolation and Characterization of Circulating Tumor Cells (CTCs)
- How to Decide Between 2D and 3D Cell Cultures?
- Neural Differentiation from Induced Pluripotent Stem Cells
- Isolation, Expansion, and Analysis of Natural Killer Cells
- Tumor Stem Cells: Identification, Isolation and Therapeutic Interventions
- Multi-Differentiation of Peripheral Blood Mononuclear Cells
- Human Primary Cells: Definition, Assay, Applications
- What are Mesothelial Cells?
- How to Scale Up Single-Cell Clones?
- T Cell, NK Cell Differentiation from Induced Pluripotent Stem Cells
- Major Problems Caused by the Use of Uncharacterized Cell Lines
- Cell Culture Medium
- IL-12 Family Cytokines and Their Immune Functions
- Critical Quality Attributes and Assays for Induced Pluripotent Stem Cells
- Direct vs. Indirect Cell-Based ELISA
- What Is Cell Proliferation and How to Analyze It?
- Unveiling the Molecular Secrets of Adipogenesis in MSCs
- CHO Cell Line Development
- How to Eliminate Mycoplasma From Cell Cultures?
- Troubleshooting Cell Culture Contamination: A Comprehensive Guide
- How to Isolate PBMCs from Whole Blood?
- Strategies for Enrichment of Circulating Tumor Cells (CTCs)
- How to Handle Mycoplasma in Cell Culture?
- Spheroid vs. Organoid: Choosing the Right 3D Model for Your Research
- From Collection to Cure: How ACT Works in Cancer Immunotherapy
- Optimization Strategies of Cell-Based Assays
- Cell-Based High-Throughput Screening Techniques
- Overview of Cell Apoptosis Assays
- From Blur to Clarity: Solving Resolution Limits in Live Cell Imaging
- Key Techniques in Primary, Immortalized and Stable Cell Line Development
- Cell Immortalization Step by Step
- Adherent and Suspension Cell Culture
- Live Cell Imaging: Unveiling the Dynamic World of Cellular Processes
- Cell Viability, Proliferation and Cytotoxicity Assays
- What Are CAR T Cells?
- From Primary to Immortalized: Navigating Key Cell Lines in Biomedical Research
- Live Cell Imaging: Unveiling the Dynamic World of Cellular Processes
- Optimization Strategies of Cell-Based Assays
- From Blur to Clarity: Solving Resolution Limits in Live Cell Imaging
- Immunogenicity Testing: ELISA and MSD Assays
- Cultivated Meat: What to Know?
- 3D-Cell Model in Cell-Based Assay
- Eosinophils vs. Basophils vs. Neutrophils
- 3D-Cell Model in Cell-Based Assay
- What Are the Pros and Cons of Adoptive Cell Therapy?
- How to Maximize Efficiency in Cell-Based High-Throughput Screening?
- Immunogenicity Testing: ELISA and MSD Assays
- What are White Blood Cells?
- Types of Cell Therapy for Cancer
- Role of Cell-Based Assays in Drug Discovery and Development
- Exploring Cell Dynamics: Migration, Invasion, Adhesion, Angiogenesis, and EMT Assays
- A Complete Guide to Immortalized Cancer Cell Lines in Cancer Research
- Mastering Cell Culture and Cryopreservation: Key Strategies for Optimal Cell Viability and Stability
- Understanding Immunogenicity Assays: A Comprehensive Guide
-
Histology
- Troubleshooting in Fluorescent Staining
- Stains Used in Histology
- Fluorescent Nuclear Staining Dyes
- Immunohistochemistry Controls
- Overview of the FFPE Cell Pellet Product Lines
- Tips for Choosing the Right Protease Inhibitor
- How to Apply NGS Technologies to FFPE Tissues?
- Overview of Common Tracking Labels for MSCs
- Multiple Animal Tissue Arrays
- Cell and Tissue Fixation
- Immunohistochemistry Troubleshooting
- Comparison of Membrane Stains vs. Cell Surface Stains
- Microscope Platforms
- Cell Lysates: Composition, Properties, and Preparation
- Mitochondrial Staining
- Guides for Live Cell Imaging Dyes
- Instructions for Tumour Tissue Collection, Storage and Dissociation
- How to Choose the Right Antibody for Immunohistochemistry (IHC)
- How to Begin with Multiplex Immunohistochemistry (mIHC)
- Common Immunohistochemistry Stains and Their Role in Cancer Diagnosis
- How Immunohistochemistry Makes the Invisible Brain Visible?
- Histological Staining Techniques: From Traditional Chemical Staining to Immunohistochemistry
- Multiplexing Immunohistochemistry
- What You Must Know About Neuroscience IHC?
- From Specimen to Slide: Core Methods in Histological Practice
- Modern Histological Techniques
- Comparing IHC, ICC, and IF: Which One Fits Your Research?
- Serum vs. Plasma
-
Exosome
- How do PELN Deliver Drugs?
- Current Research Status of Milk Exosomes
- Classification, Isolation Techniques and Characterization of Exosomes
- Emerging Technologies and Methodologies for Exosome Research
- Collection of Exosome Samples and Precautions
- Common Techniques for Exosome Nucleic Acid Extraction
- How Important are Lipids in Exosome Composition and Biogenesis?
- How to characterize exosomes?
- How to Enhancement Exosome Production?
- Production of Exosomes: Human Cell Lines and Cultivation Modes
- Techniques for Exosome Quantification
- How to Perform Targeted Modification of Exosomes?
- Exosomes as Emerging Biomarker Tools for Diseases
- How to Apply Exosomes in Clinical?
- Exosome Transfection for Altering Biomolecular Delivery
- Summary of Approaches for Loading Cargo into Exosomes
- Exosome Antibodies
- Exosome Quality Control: How to Do It?
- Applications of MSC-EVs in Immune Regulation and Regeneration
- What are the Functions of Exosomal Proteins?
- Exosome Size Measurement
- The Role of Exosomes in Cancer
- Unraveling Biogenesis and Composition of Exosomes
- What's the Potential of PELN in Disease Treatment?
- How to Label Exosomes?
- How to Efficiently Utilize MSC Exosomes for Disease Treatment?
-
ISH/FISH
- ISH probe labeling method
- Multiple Approaches to Karyotyping
- In Situ Hybridization Probes
- CARD-FISH: Illuminating Microbial Diversity
- Comprehensive Comparison of IHC, CISH, and FISH Techniques
- RNAscope ISH Technology
- Overview of Common FISH Techniques
- Guidelines for the Design of FISH Probes
- Differences Between DNA and RNA Probes
- Comparative Genomic Hybridization and Its Applications
- What are the Differences between FISH, aCGH, and NGS?
- Small RNA Detection by ISH Methods
- How to Use FISH in Hematologic Neoplasms?
- FISH Tips and Troubleshooting
- What Is the Use of FISH in Solid Tumors?
- Overview of Oligo-FISH Technology
- Multiple Options for Proving Monoclonality
- FISH Techniques for Biofilm Detection
- Whole Chromosome Painting Probes for FISH
- Telomere Length Measurement Methods
- What Types of Multicolor FISH Probe Sets Are Available?
- Different Types of FISH Probes for Oncology Research
- Reagents Used in FISH Experiments
- What are Single, Dual, and Multiplex ISH?
- Mapping of Transgenes by FISH
- ImmunoFISH: Integrates FISH and IL for Dual Detection
- 9 ISH Tips You Can't Ignore
-
Toxicokinetics & Pharmacokinetics
- Toxicokinetics vs. Pharmacokinetics
- Organoids in Drug Discovery: Revolutionizing Therapeutic Research
- What Are Metabolism-Mediated Drug-Drug Interactions?
- How to Improve Drug Plasma Stability?
- How Is the Cytotoxicity of Drugs Determined?
- How to Improve the Pharmacokinetic Properties of Peptides?
- Key Factors Influencing Brain Distribution of Drugs
- How to Conduct a Bioavailability Assessment?
- Experimental Methods for Identifying Drug-Drug Interactions
- Organ-on-a-Chip Systems for Drug Screening
- Key Considerations in Toxicokinetic
- Effects of Cytochrome P450 Metabolism on Drug Interactions
- How to Improve Drug Distribution in the Brain
- Overview of In Vitro Permeability Assays
- Traditional vs. Novel Drug Delivery Methods
- What factors influence drug distribution?
- How to Design and Synthesize Antibody Drug Conjugates?
- What Is the Role of the Blood-Brain Barrier in Drug Delivery?
- Parameters of Pharmacokinetics: Absorption, Distribution, Metabolism, Excretion
- Physical and Chemical Properties of Drugs and Calculations
- Predictive Modeling of Metabolic Drug Toxicity
- Comparison of MDCK-MDR1 and Caco-2 Cell-Based Permeability Assays
- Methods of Parallel Artificial Membrane Permeability Assays
- Unraveling the Role of hERG Channels in Drug Safety
- What Are Compartment Models in Pharmacokinetics?
- What are the Pharmacokinetic Properties of the Antisense Oligonucleotides?
- The Rise of In Vitro Testing in Drug Development
- Pharmacokinetics Considerations for Antibody Drug Conjugates
- Pharmacokinetics of Therapeutic Peptides
- The 8 Costliest Mistakes in Preclinical CYP Phenotyping
- When Should You Introduce ADME Tox Testing in Drug Development?
- 6 Easy Steps to Get Your In Vitro ADME Done
- From Cells to Systems: Modern Approaches to Disease Modeling
- How to Choose the Right In Vitro ADME Assays for Small-Molecule Drugs
- How Genotoxicity Testing Guides Safer Drug Development
- Top 5 Pitfalls in In Vitro ADME Assays and How to Avoid Them
- What Is Genotoxicity in Pharmacology? Mechanisms and Sources
- In Vitro ADME vs In Vivo ADME
- A Complete Guide to CYP Reaction Phenotyping in 2026
- How to Interpret CYP Phenotyping Data
- Reaction Phenotyping vs. Metabolic Stability
- Why Cardiotoxicity Matters in R&D?
- What Are the Best Methods to Test Cardiotoxicity?
-
Disease Models
- Animal Models of Neurodegenerative Diseases
- Summary of Advantages and Limitations of Different Oncology Animal Models
- Disease Models of Diabetes Mellitus
- What Human Disease Models Are Available for Drug Development?
- Overview of Cardiovascular Disease Models in Drug Discovery
- Why Use PDX Models for Cancer Research?
- Preclinical Models of Acute Liver Failure
-
Cell Biology
- Life Science Articles
- Download Center
- Trending Newsletter


